Combination therapy with zidovudine, didanosine and saquinavir

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 99-

  Collier, A C ^a   Coombs, R W ^a   Schoenfeld, D A ^a   Bassett, R ^a   Baruch, A ^a   Corey, L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CD4+ cell; Combination therapy; HIV 1 microculture; HIV 1 RNA; Phase II clinical trial; Quantitative; Saquinavir; Zalcitabine; Zidovudine

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; PROTEINASE INHIBITOR; SAQUINAVIR; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029864682     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00928-0     Document Type: Conference Paper

References (0)